Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
XP Insider Sold Shares Worth $2,413,865, According to a Recent SEC Filing

XP Insider Sold Shares Worth $2,413,865, According to a Recent SEC Filing

MT newswireMT newswire2026/09/18 07:41
03:41 AM EDT, 09/18/2026 (MT Newswires) -- Bruno Constantino Alexandre Dos Santos, Director, on September 16, 2026, sold 123,257 shares in XP (XP) for $2,413,865. Following the Form 4 filing with the SEC, Dos Santos has control over a total of 1,500,000 Class A common shares of the company, with 1,500,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1787425/000095010326014163/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver

Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

智通财经•2026/11/05 02:41
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

智通财经•2026/11/05 01:51
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response

According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.

智通财经•2026/11/05 01:36